317 related articles for article (PubMed ID: 21873688)
1. A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis.
Veenbergen S; Bennink MB; Affandi AJ; Bessis N; Biton J; Arntz OJ; van den Berg WB; van de Loo FA
Ann Rheum Dis; 2011 Dec; 70(12):2167-75. PubMed ID: 21873688
[TBL] [Abstract][Full Text] [Related]
2. Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis.
Veenbergen S; Bennink MB; de Hooge AS; Arntz OJ; Smeets RL; van den Berg WB; van de Loo FA
Arthritis Rheum; 2008 Dec; 58(12):3742-52. PubMed ID: 19035473
[TBL] [Abstract][Full Text] [Related]
3. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
[TBL] [Abstract][Full Text] [Related]
4. The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses.
Veenbergen S; Smeets RL; Bennink MB; Arntz OJ; Joosten LA; van den Berg WB; van de Loo FA
Ann Rheum Dis; 2010 Jan; 69(1):276-83. PubMed ID: 19188194
[TBL] [Abstract][Full Text] [Related]
5. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner.
Coppieters K; Van Beneden K; Jacques P; Dewint P; Vervloet A; Vander Cruyssen B; Van Calenbergh S; Chen G; Franck RW; Verbruggen G; Deforce D; Matthys P; Tsuji M; Rottiers P; Elewaut D
J Immunol; 2007 Aug; 179(4):2300-9. PubMed ID: 17675491
[TBL] [Abstract][Full Text] [Related]
6. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
7. The requirement of natural killer T-cells in tolerogenic APCs-mediated suppression of collagen-induced arthritis.
Jung S; Park YK; Shin JH; Lee H; Kim SY; Lee GR; Park SH
Exp Mol Med; 2010 Aug; 42(8):547-54. PubMed ID: 20610917
[TBL] [Abstract][Full Text] [Related]
8. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
9. SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis.
Nakaya M; Hashimoto M; Nakagawa R; Wakabayashi Y; Ishizaki T; Takada I; Komai K; Yoshida H; Yoshimura A
J Immunol; 2009 Dec; 183(11):7047-53. PubMed ID: 19915050
[TBL] [Abstract][Full Text] [Related]
10. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of splenic invariant NKT cell activation dictates localization in vivo.
King IL; Amiel E; Tighe M; Mohrs K; Veerapen N; Besra G; Mohrs M; Leadbetter EA
J Immunol; 2013 Jul; 191(2):572-82. PubMed ID: 23785119
[TBL] [Abstract][Full Text] [Related]
12. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
13. Specific deletion of LDL receptor-related protein on macrophages has skewed in vivo effects on cytokine production by invariant natural killer T cells.
Covarrubias R; Wilhelm AJ; Major AS
PLoS One; 2014; 9(7):e102236. PubMed ID: 25050824
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-expanded CD11b+ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1.
Han Y; Jiang Z; Chen Z; Gu Y; Liu Y; Zhang X; Cao X
J Autoimmun; 2015 Apr; 58():21-35. PubMed ID: 25592391
[TBL] [Abstract][Full Text] [Related]
15. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
16. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
17. Natural killer T cells promote collagen-induced arthritis in DBA/1 mice.
Jung S; Shin HS; Hong C; Lee H; Park YK; Shin JH; Hong S; Lee GR; Park SH
Biochem Biophys Res Commun; 2009 Dec; 390(3):399-403. PubMed ID: 19737532
[TBL] [Abstract][Full Text] [Related]
18. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
[TBL] [Abstract][Full Text] [Related]
19. Human Invariant Natural Killer T Cells Respond to Antigen-Presenting Cells Exposed to Lipids from Olea europaea Pollen.
Abos Gracia B; López Relaño J; Revilla A; Castro L; Villalba M; Martín Adrados B; Regueiro JR; Fernández-Malavé E; Martínez Naves E; Gómez Del Moral M
Int Arch Allergy Immunol; 2017; 173(1):12-22. PubMed ID: 28486236
[TBL] [Abstract][Full Text] [Related]
20. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
